MarketInOut Stock Screener Log In | Sign Up

Viking Therapeutics Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/30/2026
Viking Therapeutics Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization3,403.57 mln
Float123 mln
Earnings Date02/10/2027

Piotroski F-Score

1 / 9
Very weak

1-Year Forecast

95.32
Transformational upside

Relative Strength

90 / 100
Top performer

Debt / Equity

0.43
Low leverage

ROE

-110
Deeply negative

ROA

-88.03
Deeply negative

Business Description

Viking Therapeutics is a San Diego-based company founded in 2012 that researches and develops new medicines targeting hormonal and metabolic diseases. The company has several drugs in clinical testing, addressing conditions such as liver disease, muscle loss following hip fractures, and rare genetic disorders. Its most advanced treatments work by selectively targeting specific receptors in the body, aiming to deliver therapeutic benefits while minimizing unwanted side effects.

Key Fundamentals

EPS-5.42
ROE-110
ROIC-31,990
ROA-88.03
Interest Cover-7,370
EBITDA, mln-627
EV / EBITDA-3.86
EV / EBIT-3.85

Quote Details

Last 27.28
Change 0.42 (1.56%)
Open 26.77
Volume 5,080,556
Turnover 138,597,568
Average Volume 5,119,281

Financial Ratios

Leverage Ratio1.66
Current Ratio7.27
Price / Book5.84
Price / Tangible Book5.84
Debt / Equity0.43

Financial Strength

Piotroski F-Score 1 / 9
1-Year Target Price95.32
Short Ratio2.88
Short % of Float21.06

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 11.8% 95 / 100   
1 Month -10.59% 28 / 100   
2 Months -21.77% 21 / 100   
6 Months -9.07% 37 / 100   
1 Year -22.54% 29 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog